Cargando…
Characterization of cholesterol homeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts reveals a Niemann-Pick disease type C-like phenotype with enhanced lysosomal Ca(2+) storage
Sphingosine-1-phosphate (S1P) lyase irreversibly cleaves S1P, thereby catalysing the ultimate step of sphingolipid degradation. We show here that embryonic fibroblasts from S1P lyase-deficient mice (Sgpl1(−/−)-MEFs), in which S1P and sphingosine accumulate, have features of Niemann-Pick disease type...
Autores principales: | Vienken, Hans, Mabrouki, Nathalie, Grabau, Katja, Claas, Ralf Frederik, Rudowski, Agnes, Schömel, Nina, Pfeilschifter, Josef, Lütjohann, Dieter, van Echten-Deckert, Gerhild, Meyer zu Heringdorf, Dagmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337937/ https://www.ncbi.nlm.nih.gov/pubmed/28262793 http://dx.doi.org/10.1038/srep43575 |
Ejemplares similares
-
Sphingosine‐1‐phosphate‐lyase deficiency affects glucose metabolism in a way that abets oncogenesis
por: Afsar, Sumaiya Y., et al.
Publicado: (2022) -
S1P Lyase Deficiency in the Brain Promotes Astrogliosis and NLRP3 Inflammasome Activation via Purinergic Signaling
por: Alam, Shah, et al.
Publicado: (2023) -
SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production
por: Mitroi, Daniel N., et al.
Publicado: (2017) -
Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks
por: Blankenbach, Kira V., et al.
Publicado: (2016) -
Lysosomal and Mitochondrial Liaisons in Niemann-Pick Disease
por: Torres, Sandra, et al.
Publicado: (2017)